Compared with HFD treatment, ML‐inulin supplementation significantly decreased weight gain, hepatic steatosis, chronic inflammation, and increased insulin sensitivity, energy expenditure and thermogenesis. The gene discussed is INS; the disease is Hepatic steatosis.